Specific programme: Industrial Leadership: ECSEL Joint Undertaking
UPV/EHU Partner Status: Beneficiary
UPV/EHU PI: Lola Boyano
Project start: 01/06/2016
Project end:   31/03/2019

Brief description: Professional care in the hospitals has seen a recent revolution in the way patients are treated: from open invasive surgery towards minimally invasive interventions. This approach is highly efficient and safe and has minimal side-effects. Patients enjoy a shorter recovery period. Treatment can be easily repeated and has the benefit of not doing harm to healthy anatomical structures and physiological functions. The ASTONISH project will address these key items by developing smart optical imaging technology that will extend the use of invasive diagnosis and treatment and will allow for unobtrusive health monitoring. From a technology point of view, optical imaging is a very promising emerging technology with great potential to improve disease prevention, diagnosis and treatment. Furthermore optical imaging can easily be combined with other imaging and sensing techniques, to provide enhanced information for doctors treating complex diseases. ASTONISH will develop innovative sensing and integrated read-out architectures for a new generation of medical diagnostic systems based on NIR, PPG, hyper spectral imaging and ECG. The overall concept within ASTONISH builds on the development and application of common imaging/sensing technologies, sophisticated algorithms, multimodal fusion techniques and biomedical signal processing to process the acquired data and advanced user interfaces to visualize the acquired data and simplify the complex clinical tasks. These technology building blocks will be used to develop application specific solutions for physiological signs monitoring, tumor detection, minimally invasive surgery, brain function monitoring and rehabilitation. The ASTONISH partners cover the full value chain, from semiconductor manufacturing to clinical application. The proposed
innovations will improve the global competitiveness of the European industry in the Healthcare Market and a significant gain of both the electronic and the imaging market share can be gained.